Drugs that contain Cyclobenzaprine Hydrochloride
1. List of Amrix drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7829121 | TEVA PHARMS INTL | Modified release dosage forms of skeletal muscle relaxants |
Nov, 2023
(9 months from now) | |
| US9375410 | TEVA PHARMS INTL | Modified release dosage forms of skeletal muscle relaxants |
Nov, 2023
(9 months from now) | |
| US9399025 | TEVA PHARMS INTL | Modified release dosage forms of skeletal muscle relaxants |
Nov, 2023
(9 months from now) | |
| US8877245 | TEVA PHARMS INTL | Modified release dosage forms of skeletal muscle relaxants |
Nov, 2023
(9 months from now) | |
| US7544372 | TEVA PHARMS INTL | Modified release dosage forms of skeletal muscle relaxants |
Nov, 2023
(9 months from now) | |
| US7820203 | TEVA PHARMS INTL | Modified release dosage forms of skeletal muscle relaxants |
Nov, 2023
(9 months from now) | |
| US7790199 | TEVA PHARMS INTL | Modified release dosage forms of skeletal muscle relaxants |
Nov, 2023
(9 months from now) | |
| US7387793 | TEVA PHARMS INTL | Modified release dosage forms of skeletal muscle relaxants |
Feb, 2025
(2 years from now) | |
Market Authorisation Date: 01 February, 2007
Treatment: Relief of muscle spasm
Dosage: CAPSULE, EXTENDED RELEASE;ORAL
How can I launch a generic of AMRIX before it's patent expiration?
More Information on Dosage
availability in other generic markets.
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic